Single, subanesthetic-dose of ketamine infusion relatively free of side effects for patients with treatment-resistant depression

Nov 15, 2019: NIH researchers found that a single, subanesthetic-dose of ketamine infusion was relatively free of side effects for patients with treatment-resistant depression symptoms within hours in people who have not responded to conventional antidepressants, which typically take weeks or months to work. No drug-related serious adverse events or increased ketamine cravings with a single-administration.”“side effect of ketamine infusion found like feeling strange or loopy, difficulty speaking, visual distortions,” most side effects peaked within an hour of ketamine administration and were gone within two hours.  https://www.nih.gov/news-events/news-releases/side-effects-mild-brief-single-antidepressant-dose-intravenous-ketamine